A composite hydrogel platform for the dissection of tumor cell migration at tissue interfaces

Biomaterials

Volumn 35, Issue 31, 2014, Pages 8846-8853

  Rape, Andrew D ^a   Kumar, Sanjay ^a  

^a University of California at Berkeley   (United States)

Author keywords

Cell migration; Glioblastoma; Hyaluronic acid; Polyacrylamide

Indexed keywords

BLOOD VESSELS; DISSECTION; ORGANIC ACIDS; POLYACRYLATES; PROTEINS; TUMORS;

ADHESIVE SIGNALING; CELL MIGRATION; COMPOSITE HYDROGELS; GLIOBLASTOMA MULTIFORME; GLIOBLASTOMAS; SURGICAL RESECTION; TUMOR CELL MIGRATION; WHITE MATTER TRACTS;

HYALURONIC ACID;

FIBRONECTIN; HERMES ANTIGEN; HYALURONIC ACID; INTEGRIN; METHACRYLIC ACID; MYOSIN II; ACRYLIC ACID RESIN; BIOMATERIAL; HYDROGEL; POLYACRYLAMIDE;

ARTICLE; BASEMENT MEMBRANE; BLOOD VESSEL; BRAIN TISSUE; CELL ADHESION; CELL CULTURE; CELL INFILTRATION; CELL MIGRATION; CELL MOTILITY; DISSECTION; DORSAL ADHESION; FLUORESCENCE MICROSCOPY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HYDROGEL; MECHANOTRANSDUCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; STEREOSPECIFICITY; SURFACE PROPERTY; TUMOR CELL; WHITE MATTER; BRAIN; BRAIN TUMOR; CELL LINE; CELL MOTION; CHEMISTRY; CULTURE TECHNIQUE; METABOLISM; PATHOLOGY; PROCEDURES;

ACRYLIC RESINS; ANTIGENS, CD44; BRAIN; BRAIN NEOPLASMS; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL LINE; CELL MOVEMENT; COATED MATERIALS, BIOCOMPATIBLE; GLIOBLASTOMA; HUMANS; HYALURONIC ACID; HYDROGEL; INTEGRINS; MYOSIN TYPE II;

EID: 84905442660     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.07.003     Document Type: Article

References (48)

1. Pathak A., Kumar S. Biophysical regulation of tumor cell invasion: moving beyond matrix stiffness. Integr Biol 2011, 3(4):267-278.
2. Sahai E., Marshall C.J. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 2003, 5(8):711-719.
3. Doyle A.D., Wang F.W., Matsumoto K., Yamada K.M. One-dimensional topography underlies three-dimensional fibrillar cell migration. J Cell Biol 2009, 184(4):481-490.
4. Lauffenburger D.A., Horwitz A.F. Cell migration: a physically integrated molecular process. Cell 1996, 84(3):359-369.
5. Friedl P., Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003, 3(5):362-374.
6. Friedl P., Wolf K. Plasticity of cell migration: a multiscale tuning model. J Cell Biol 2009, 188(1):11-19.
7. Tozluoǧlu M., Tournier A.L., Jenkins R.P., Hooper S., Bates P.A., Sahai E. Matrix geometry determines optimal cancer cell migration strategy and modulates response to interventions. Nat Cell Biol 2013, 15(7):751-762.
8. Petrie R.J., Gavara N., Chadwick R.S., Yamada K.M. Nonpolarized signaling reveals two distinct modes of 3D cell migration. J Cell Biol 2012, 197(3):439-455.
9. Condeelis J., Segall J.E. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003, 3(12):921-930.
10. Friedl P., Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011, 147(5):992-1009.
11. Alexander S., Koehl G.E., Hirschberg M., Geissler E.K., Friedl P. Dynamic imaging of cancer growth and invasion: a modified skin-fold chamber model. Histochem Cell Biol 2008, 130(6):1147-1154.
12. Gritsenko G.P., Ilina O., Friedl P. Interstitial guidance of cancer invasion. J Pathol 2012, 226(2):185-199.
13. Wolf K., Alexander S., Schacht V., Coussens L.M., von Andrian U.H., van Rheenen J., et al. Collagen-based cell migration models in vitro and in vivo. Semin Cell Dev Biol 2009, 20(8):931-941.
14. Agnihotri S., Burrell K.E., Wolf A., Jalali S., Hawkins C., Rutka J.T., et al. Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies. Arch Immunol Ther Exp 2013, 61(1):25-41.
15. Bernstein J.J., Woodard C.A. Glioblastoma cells do not intravasate into blood vessels. Neurosurgery 1995, 36(1):124-132.
16. Scherer H.J. The forms of growth in gliomas and their practical significance. Brain 1940, 63(1):1-35.
17. Laurent T.C., Fraser J.R. Hyaluronan. Faseb J 1992, 6(7):2397-2404.
18. Toole B.P. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004, 4(7):528-539.
19. O'Rourke M.F., Staessen J.A., Vlachopoulos C., Duprez D., Plante G.E. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 2002, 15(5):426-444.
20. Levental I., Georges P.C., Janmey P.A. Soft biological materials and their impact on cell function. Soft Matter 2012, 3:299-306.
21. Zhang Xiaoming, Kinnick R.R., Fatemi M., Greenleaf J.F. Noninvasive method for estimation of complex elastic modulus of arterial vessels. IEEE Trans Ultrason Ferroelectr Freq Control 2005, 52(4):642-652.
22. Ananthanarayanan B., Kim Y., Kumar S. Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform. Biomaterials 2011, 32(31):7913-7923.
23. Ulrich T.A., de Juan Pardo E.M., Kumar S. The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells. Cancer Res 2009, 69(10):4167-4174.
24. Marklein R.A., Burdick J.A. Spatially controlled hydrogel mechanics to modulate stem cell interactions. Soft Matter 2010, 6:136-143.
25. Torsvik A., Røsland G.V., Svendsen A., Molven A., Immervoll H., McCormack E., et al. Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter. Cancer Res 2010, 70(15):6393-6396.
26. Kim Y., Kumar S. CD44-mediated Adhesion to hyaluronic acid contributes to mechanosensing and invasive motility. Mol Cancer Res 2014, in press. 10.1158/1541-7786.MCR-13-062.
27. Wang Y.L., Pelham R.J. Preparation of a flexible, porous polyacrylamide substrate for mechanical studies of cultured cells. Meth Enzymol 1998, 298:489-496.
28. Rehfeldt F., Brown A.E.X., Raab M., Cai S., Zajac A.L., Zemel A., et al. Hyaluronic acid matrices show matrix stiffness in 2D and 3D dictates cytoskeletal order and myosin-II phosphorylation within stem cells. Integr Biol 2012, 4(4):422-430.
29. Ponta H., Sherman L., Herrlich P.A. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 2003, 4(1):33-45.
30. Pietras A., Katz A.M., Ekström E.J., Wee B., Halliday J.J., Pitter K.L., et al. Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. Cell Stem Cell 2014, 14(3):357-369.
31. Bourdon M.A., Ruoslahti E. Tenascin mediates cell attachment through an RGD-dependent receptor. J Cell Biol 1989, 108(3):1149-1155.
32. Castellani P., Dorcaratto A., Siri A., Zardi L., Viale G.L. Tenascin distribution in human brain tumours. Acta Neurochir 1995, 136(1-2):44-50.
33. Beningo K.A., Dembo M., Wang Y. Responses of fibroblasts to anchorage of dorsal extracellular matrix receptors. Proc Natl Acad Sci U S A 2004, 101(52):18024-18029.
34. Kuo J.-C., Han X., Hsiao C.-T., Yates J.R., Waterman C.M. Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-pix in negative regulation of focal adhesion maturation. Nat Cell Biol 2011, 13(4):383-393.
35. Pasapera A.M., Schneider I.C., Rericha E., Schlaepfer D.D., Waterman C.M. Myosin II activity regulates vinculin recruitment to focal adhesions through FAK-mediated paxillin phosphorylation. J Cell Biol 2010, 188(6):877-890.
36. Oakes P.W., Beckham Y., Stricker J., Gardel M.L. Tension is required but not sufficient for focal adhesion maturation without a stress fiber template. J Cell Biol 2012, 196(3):363-374.
37. Han S.J., Bielawski K.S., Ting L.H., Rodriguez M.L., Sniadecki N.J. Decoupling substrate stiffness, spread area, and micropost density: a close spatial relationship between traction forces and focal adhesions. Biophys J 2012, 103(4):640-648.
38. Solon J., Levental I., Sengupta K., Georges P.C., Janmey P.A. Fibroblast adaptation and stiffness matching to soft elastic substrates. Biophys J 2007, 93(12):4453-4461.
39. Sen S., Dong M.M., Kumar S. Isoform-specific contributions of alpha-actinin to glioma cell mechanobiology. PloS One 2009, 4(12). e8427.
40. Keung A.J., de Juan-Pardo E.M., Schaffer D.V., Kumar S. Rho GTPases mediate the mechanosensitive lineage commitment of neural stem cells. Stem Cells 2011, 29(11):1886-1897.
41. Ariza A., López D., Mate J.L., Isamat M., Musulén E., Pujol M., et al. Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: an immunohistochemistry study. Hum Pathol 1995, 26(10):1144-1147.
42. Mehta G., Williams C.M., Alvarez L., Lesniewski M., Kamm R.D., Griffith L.G. Synergistic effects of tethered growth factors and adhesion ligands on DNA synthesis and function of primary hepatocytes cultured on soft synthetic hydrogels. Biomaterials 2010, 31(17):4657-4671.
43. Poincloux R., Collin O., Lizárraga F., Romao M., Debray M., Piel M., et al. Contractility of the cell rear drives invasion of breast tumor cells in 3D Matrigel. Proc Natl Acad Sci U S A 2011, 108(5):1943-1948.
44. Wolf K., Friedl P. Molecular mechanisms of cancer cell invasion and plasticity. Br J Dermatol 2006, 154(1):11-15.
45. Piao Y., Lu L., de Groot J. AMPA receptors promote perivascular glioma invasion via β1 integrin-dependent adhesion to the extracellular matrix. Neuro Oncol 2009, 11(3):260-273.
46. Paulus W., Baur I., Beutler A.S., Reeves S.A. Diffuse brain invasion of glioma cells requires beta 1 integrins. Lab Invest 1996, 75(6):819-826.
47. Reardon D.A., Zalutsky M.R., Akabani G., Coleman R.E., Friedman A.H., Herndon J.E., et al. A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost. Neuro Oncol 2008, 10(2):182-189.
48. 6-methylguanine-DNA methyltransferase (MGMT) gene promoter: key results of the multicenter, randomized, open-label, controlled, phase III centric study. J Clin Oncol 2013, 31.